DiagnoCure Announces First Quarter 2014 Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

QUEBEC CITY, March 14, 2014 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR) (OTCQX: DGCRF) (the “Corporation”) today reported financial and operational results for the first quarter 2014 ended January 31, 2014. The Corporation announced a net loss of $529,739 or $0.01 per share for this quarter. At the end of the quarter, cash, cash equivalents and short-term investments stood at $3,543,029.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC